ImportRefusal LogoImportRefusal

Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd.

⚠️ Moderate Risk

FEI: 3003465866 • Shenzhen, Guangdong • CHINA

FEI

FEI Number

3003465866

📍

Location

Shenzhen, Guangdong

🇨🇳

Country

CHINA
🏢

Address

1028 Beihuan Blvd., , Shenzhen, Guangdong, China

Moderate Risk

FDA Import Risk Assessment

42.6
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

19
Total Refusals
12
Unique Violations
4/1/2021
Latest Refusal
10/27/2005
Earliest Refusal

Score Breakdown

Violation Severity
65.0×40%
Refusal Volume
48.2×30%
Recency
4.4×20%
Frequency
12.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

21205×

UNSFDIETSP

The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

31203×

EPHEDALK

The product is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a dietary supplement or a dietary ingredient that appears to contain ephedrine alkaloids, which presents an unreasonable risk of illness or injury under the conditions of use recommended or suggested in the labeling, or if no conditions of use are suggested in the labeling, under ordinary conditions of use.

4723×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

37412×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

2562×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
4/1/2021
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/20/2013
66V99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/1/2013
66VBR99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
3/7/2013
61XBE08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
12/15/2011
54FER99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
256INCONSPICU
New York District Office (NYK-DO)
1/20/2011
54EEY99HERBALS & BOTANICAL TEAS, N.E.C.
324NO ENGLISH
New York District Office (NYK-DO)
11/9/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
Los Angeles District Office (LOS-DO)
9/28/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
Los Angeles District Office (LOS-DO)
9/28/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
Los Angeles District Office (LOS-DO)
6/19/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3120EPHEDALK
Los Angeles District Office (LOS-DO)
6/19/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3120EPHEDALK
Los Angeles District Office (LOS-DO)
6/19/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
Los Angeles District Office (LOS-DO)
6/17/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3120EPHEDALK
Los Angeles District Office (LOS-DO)
6/17/2009
54FBR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
Los Angeles District Office (LOS-DO)
2/24/2009
53LD03FACE,BODY,AND HAND (EXCLUDING SHAVING PREPARATIONS) (SKIN CARE PREPARATIONS)
218LIST INGRE
75UNAPPROVED
New York District Office (NYK-DO)
2/20/2009
54YBY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
New York District Office (NYK-DO)
2/12/2009
54YCC99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
256INCONSPICU
75UNAPPROVED
Cincinnati District Office (CIN-DO)
2/12/2009
54YCC99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
10/27/2005
66VBH99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd.'s FDA import refusal history?

Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd. (FEI: 3003465866) has 19 FDA import refusal record(s) in our database, spanning from 10/27/2005 to 4/1/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd.'s FEI number is 3003465866.

What types of violations has Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd. received?

Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd. has been cited for 12 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd. come from?

All FDA import refusal data for Shenzhen 999 Chinese Medicine Investment & Dev. Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.